Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer International Publishing

9783319067513, 9783319067520

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_8 ◽

2014 ◽

pp. 205-231

Author(s):

Jason I. Kass ◽

Jennifer R. Grandis ◽

Daniel E. Johnson

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Proteasome Inhibitors ◽

New Approaches

Download Full-text

Preclinical Studies on the Molecular Basis of Bortezomib Resistance and Modalities to Overcome Resistance in Hematological Malignancies

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_7 ◽

2014 ◽

pp. 181-204 ◽

Cited By ~ 1

Author(s):

Jacqueline Cloos ◽

Denise Niewerth ◽

Gerrit Jansen

Keyword(s):

Molecular Basis ◽

Hematological Malignancies ◽

Preclinical Studies

Download Full-text

Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_4 ◽

2014 ◽

pp. 99-115

Author(s):

Jeffrey A. Zonder

Keyword(s):

Multiple Myeloma ◽

Proteasome Inhibitors ◽

Al Amyloidosis

Download Full-text

Targeting the Proteasome Pathway for the Treatment of Solid Tumors

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_9 ◽

2014 ◽

pp. 233-248

Author(s):

Nisar Ahmad ◽

Elias Anaissie ◽

Mohamed A. Y. Abdel Malek ◽

James J. Driscoll

Keyword(s):

Solid Tumors ◽

Proteasome Pathway

Download Full-text

Proteasome Inhibitors Versus E3 Ligase Inhibitors for Cancer Therapy

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_12 ◽

2014 ◽

pp. 291-316 ◽

Cited By ~ 1

Author(s):

Michael R. Mattern ◽

Michael J. Eddins ◽

Saket Agarwal ◽

David E. Sterner ◽

Matthew P. Kodrasov ◽

...

Keyword(s):

Cancer Therapy ◽

Proteasome Inhibitors ◽

E3 Ligase

Download Full-text

Resistance to Proteasome Inhibitors in Multiple Myeloma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_2 ◽

2014 ◽

pp. 47-80 ◽

Cited By ~ 3

Author(s):

Francesca Cottini ◽

Anna Guidetti ◽

Claudia Paba Prada ◽

Teru Hideshima ◽

Michelle Maglio ◽

...

Keyword(s):

Multiple Myeloma ◽

Proteasome Inhibitors

Download Full-text

Proteotoxic Stress and Proteasome Inhibitor Efficacy and Resistance

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_11 ◽

2014 ◽

pp. 275-289

Author(s):

David McConkey

Keyword(s):

Proteasome Inhibitor ◽

Proteotoxic Stress

Download Full-text

Oxidative Stress and the Proteasome: Mechanisms and Therapeutic Relevance

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_10 ◽

2014 ◽

pp. 249-274 ◽

Cited By ~ 2

Author(s):

Christa Manton ◽

Joya Chandra

Keyword(s):

Oxidative Stress ◽

Therapeutic Relevance

Download Full-text

Overcoming Bortezomib Resistance: A Review of the Second-Generation Proteasome Inhibitor Carfilzomib in the Treatment of Multiple Myeloma

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_3 ◽

2014 ◽

pp. 81-98

Author(s):

Hans C. Lee ◽

Robert Z. Orlowski

Keyword(s):

Multiple Myeloma ◽

Proteasome Inhibitor ◽

Second Generation

Download Full-text

Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer ◽

10.1007/978-3-319-06752-0_5 ◽

2014 ◽

pp. 117-147 ◽

Cited By ~ 1

Author(s):

Amit Kumar Mitra ◽

Holly Stessman ◽

John Shaughnessy ◽

Brian Van Ness

Keyword(s):

Multiple Myeloma

Download Full-text

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in CancerLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer International Publishing

Overcoming Inherent Resistance to Proteasome Inhibitors in Head and Neck Cancer: Challenges and New Approaches

Preclinical Studies on the Molecular Basis of Bortezomib Resistance and Modalities to Overcome Resistance in Hematological Malignancies

Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis

Targeting the Proteasome Pathway for the Treatment of Solid Tumors

Proteasome Inhibitors Versus E3 Ligase Inhibitors for Cancer Therapy

Resistance to Proteasome Inhibitors in Multiple Myeloma

Proteotoxic Stress and Proteasome Inhibitor Efficacy and Resistance

Oxidative Stress and the Proteasome: Mechanisms and Therapeutic Relevance

Overcoming Bortezomib Resistance: A Review of the Second-Generation Proteasome Inhibitor Carfilzomib in the Treatment of Multiple Myeloma

Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy

Resistance to Targeted Anti-Cancer Therapeutics - Resistance to Proteasome Inhibitors in Cancer
Latest Publications